Cargando…

BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR‐T cell cytotoxicity

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy with poor prognosis and no treatment consensus. Combining chemotherapy and immunotherapy is a promising strategy to enhance therapeutic effect. Before combining these therapies, the influence of one on the other...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poussard, Margaux, Philippe, Laure, Fredon, Maxime, Bôle‐Richard, Elodie, Biichle, Sabeha, Renosi, Florian, Perrin, Sophie, Kroemer, Marie, Limat, Samuel, Bonnefoy, Francis, Daguindau, Etienne, Deconinck, Eric, Gruson, Bérengère, Saas, Philippe, Adotévi, Olivier, Garnache‐Ottou, Francine, Angelot‐Delettre, Fanny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176134/ https://www.ncbi.nlm.nih.gov/pubmed/35846081 http://dx.doi.org/10.1002/jha2.149

Ejemplares similares

Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm
por: Philippe, Laure, et al.
Publicado: (2017)

Conventional Therapeutics in BPDCN Patients—Do They Still Have a Place in the Era of Targeted Therapies?
por: Poussard, Margaux, et al.
Publicado: (2022)

Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells
por: Caël, Blandine, et al.
Publicado: (2022)

Lymphoblastic T Cells and Mature NK Cells With the Same TCRγ Rearrangement: A Common Origin?
por: Roggy, Anne, et al.
Publicado: (2021)

Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape
por: Zalmaï, Loria, et al.
Publicado: (2020)

Plasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms
por: Roussel, Xavier, et al.
Publicado: (2022)

New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies
por: Gamonet, Clémentine, et al.
Publicado: (2016)

Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies
por: Gamonet, Clémentine, et al.
Publicado: (2016)

Small Annexin V–Positive Platelet-Derived Microvesicles Affect Prognosis in Cirrhosis: A Longitudinal Study
por: Weil, Delphine, et al.
Publicado: (2021)

NOXA as critical mediator for drug combinations in polychemotherapy
por: Ehrhardt, H, et al.
Publicado: (2012)

Acute pancreatitis associated with multibacillary polychemotherapy for leprosy
por: Maciel, Lucas Guimarães, et al.
Publicado: (2021)

Early detection of transformation to BPDCN in a patient with MDS
por: Chamoun, Kamal, et al.
Publicado: (2018)

Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia
por: Trad, Rim, et al.
Publicado: (2022)

Pro-Resolving Factor Administration Limits Cancer Progression by Enhancing Immune Response Against Cancer Cells
por: Wetzel, Audrey, et al.
Publicado: (2022)

Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications
por: Boggio, Elena, et al.
Publicado: (2023)

The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of Lymphosarcoma
por: Sen'kova, Alexandra V., et al.
Publicado: (2012)

Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN
por: Pemmaraju, N., et al.
Publicado: (2022)

Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis
por: Togami, Katsuhiro, et al.
Publicado: (2022)

Allogeneic Hematopoietic Cell Transplantation for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
por: Bashir, Qaiser, et al.
Publicado: (2022)

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in an Elderly Female: A Rare Case
por: Al-Alwan, Ahmad, et al.
Publicado: (2023)

Harnessing Apoptotic Cell Clearance to Treat Autoimmune Arthritis
por: Saas, Philippe, et al.
Publicado: (2017)

Desmoid Tumor Treated with Polychemotherapy Followed by Imatinib: A Case Report and Review of the Literature
por: Knechtel, Gudrun, et al.
Publicado: (2010)

Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy
por: Kebir, Sied, et al.
Publicado: (2012)

Adverse effects of polychemotherapy for leprosy in 13 years of follow-up at a university hospital()()
por: Tortelly, Violeta Duarte, et al.
Publicado: (2021)

Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
por: Abdallah, Mostafa, et al.
Publicado: (2023)

First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G
por: Anna, François, et al.
Publicado: (2021)

A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer.
por: Pronzato, P., et al.
Publicado: (1996)

Multidrug Resistance Phenotype in the RMS‐GR Human Rhabdomyosarcoma Cell Line Obtained after Polychemotherapy
por: Prados, Jose, et al.
Publicado: (1999)

Achievement of complete in vitro spermatogenesis in testicular tissues from prepubertal mice exposed to mono- or polychemotherapy
por: Delessard, Marion, et al.
Publicado: (2022)

Tagraxofusp for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Brief Report on Emerging Data
por: Beziat, Guillaume, et al.
Publicado: (2020)

Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN)
por: Beird, Hannah C., et al.
Publicado: (2019)

Blastische plasmazytoide dendritische Zellneoplasie (BPDCN): Eine seltene hämatologische Neoplasie mit häufiger kutaner Beteiligung
por: Nguyen, Katrin, et al.
Publicado: (2023)

Mini-Review: The Administration of Apoptotic Cells for Treating Rheumatoid Arthritis: Current Knowledge and Clinical Perspectives
por: Toussirot, Eric, et al.
Publicado: (2021)

Resolution therapy: Harnessing efferocytic macrophages to trigger the resolution of inflammation
por: Saas, Philippe, et al.
Publicado: (2022)

Is It Time to Reconsider the Lipopolysaccharide Paradigm in Acute Graft-Versus-Host Disease?
por: Daguindau, Etienne, et al.
Publicado: (2017)

Excellent Biochemical Response to Polychemotherapy with Nab-Paclitaxel/Gemcitabine in an 82-Year-Old Female with Metastatic Breast Cancer
por: Völkl, Siegfried J.
Publicado: (2014)

Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy
por: Maisonobe, Jacques-Antoine, et al.
Publicado: (2012)

Apoptotic cell infusion treats ongoing collagen-induced arthritis, even in the presence of methotrexate, and is synergic with anti-TNF therapy
por: Bonnefoy, Francis, et al.
Publicado: (2016)

HDMTX-based polychemotherapy including intraventricular therapy in elderly patients with primary CNS lymphoma: a single center series
por: Seidel, Sabine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cre4a413icl957frr45etgsb4e